Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Applications are invited for the 2014 George Herbert Hunt Travelling Scholarship to support travel abroad for clinical study or research.

The scholarship is of the value of about £3,000 and may be held with another award.  This scholarship is offered in every second year.

Candidates should either have been admitted to the Degree of Bachelor of Medicine of the University of Oxford or have passed the First Examination for the Degree of Bachelor of Medicine of the University and hold a medical degree of another British university qualifying him or her to practise medicine.  Current medical students are not eligible to apply; an award can only be made to a medical graduate who fulfils the above criteria.

Candidates are required to submit with their applications a statement of their academic record together with testimonials, and an undertaking that, if elected, they will travel abroad for a period of at least one month for the purpose of clinical study or research in medicine. 

In making the award, preference will be given to candidates who intend to engage in the practice of their profession either as surgeons or as general practitioners.

The scholar will be required to complete his or her period of travel within twelve months from the date of election, and within a reasonable period thereafter to submit to the Secretary of the Medical School for the approval of the electors a detailed report of his or her tenure of the scholarship.  Payment of nine-tenths of the scholarship will be made shortly before the period of travel, and the remaining one-tenth following the approval of the report.  The election will be made on 9 April 2014.

Applications should be sent to Mrs Laura Morgan, Medical School Office, Academic Centre, Level 2, John Radcliffe Hospital, Headington, Oxford, OX3 9DU by 21 February 2014.

Similar stories

Prestigious award for Oxford professor's diabetes work

A University of Oxford professor has been awarded the 2021 EASD-Novo Nordisk Foundation Prize for Excellence for his decades of effort to understand, prevent and combat type 1 diabetes.

Wellcome accolades for Dr Douglas

Dr Alexander (Sandy) Douglas, an investigator at the Jenner Institute, Nuffield Department of Medicine, has recently received two prestigious Wellcome accolades.

FOCUS4: a flagship trial in colorectal cancer

Professor Tim Maughan (Department of Oncology) outlines the flagship work of the FOCUS4 trials, whose results were presented last weekend at the European Society of Medical Oncology (ESMO) annual meeting

Oxford and Oracle partner to speed identification of COVID-19 variants

The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.

Vaccinated groups at highest risk of Covid-19 hospitalisation and death identified using new QCovid tool

Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalisation or death from 14 days post the second dose vaccination, when substantial immunity should be expected.